CoDa Therapeutics, Inc.

Developing a new class of therapeutics to heal wounds faster

One of medicine’s oldest challenges, tissue damage, is also among its most intractable. Acute wounds heal slowly, chronic ones sometimes not at all. Effective drug treatment has proved elusive. But by turning previous approaches on their heads CoDa Therapeutics is already seeing significant gains from a whole new class of therapeutics it is now advancing through Phase II clinical trials.